Events

Finding the right injection pen manufacturer for your medical device program can make or break your product launch. The stakes run high—regulatory submissions depend on manufacturing quality, patient safety hinges on device reliability, and commercial success requires supply chain confidence. Read More

Choosing between disposable vs reusable injection pens represents one of the first strategic decisions pharmaceutical companies face when developing self-injection products. Read More

Engineering specifications matter enormously when evaluating retatrutide injection pen device options for pharmaceutical development. Unlike patient-facing marketing materials, technical specifications determine whether a device actually meets your drug formulation requirements and regulatory needs. Read More

GLP-1 injection pen manufacturing demands specialized expertise that generic contract manufacturers simply cannot provide. Read More

When pharmaceutical companies develop GLP-1 therapies, the injection pen device they choose becomes a critical success factor. A well-engineered Semaglutide injection pen affects patient compliance, dosing accuracy, and ultimately market adoption. Read More

Sustainability in Injection Pens: Why Recycling & Circular Programs Are Becoming a New Competitive Advantage Read More

EU Drug-Device Combination Rules Are Getting More Systematic Read More

Wearable on-body injectors enable large-dose, high-viscosity biologics to shift from IV infusion to subcutaneous self-administration. Learn why OBIs are surging. Read More

Needle-free injection pens (jet injectors) are resurging to reduce needle fear and improve home self-injection. Learn how they work, benefits, and limitations. Read More